Evidence map›Paper›PMID 30686849›Full record

ArticleNuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms2019

Trials and Tribulations in the First Three Years in Operation of the SSAMS for Biomedical

T J Ognibene, K W Haack, G Bench, K W Turteltaub

Abstract read
In one paragraph

Article in Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Activation of Molecular OChemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  8. Article
  9. Naphthalene DNA Adduct Formation and Tolerance in the Lung.Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms · 2019
    Article
  10. Pharmacokinetics of [Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

T J OgnibeneCenter for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, 7000 East Ave, Livermore, CA 94551.
K W HaackCenter for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, 7000 East Ave, Livermore, CA 94551.
G BenchCenter for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, 7000 East Ave, Livermore, CA 94551.
K W TurteltaubBiology and Biotechnology Division, Lawrence Livermore National Laboratory, 7000 East Ave, Livermore, CA 94551.

Funding

Resource for the Development of Biomedical Accelerator Mass Spectrometry (AMS)P41GM103483 · NIGMS · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI TURTELTAUB, KENNETH W. · 2012 to 2019
$12.0M
NIGMS NIH HHS P41 GM103483
6 · The paper itself

Abstract

We report on the first several years of operation of our recently installed 250 kV SSAMS at LLNL, purchased to replace our 1-MV AMS system for the measurement of

Indexed as

accelerator mass spectrometrybiomedical AMSgas ion sourceSSAMS

Identifiers

PMID30686849
PMCPMC6342019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.